naltrexone has been researched along with Cholestasis, Intrahepatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greiner, A; Hebestreit, H; Jeschke, R; Kullak-Ublick, GA; Kunzmann, S | 1 |
| Amanpour, S; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Jabehdar-Maralani, P; Mirkhani, SH; Shafaroodi, H; Tavakoli, S | 1 |
| Carson, KL; Cotton, P; Hunt, CM; Sharara, AI; Tran, TT | 1 |
3 other study(ies) available for naltrexone and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Effective opiate-receptor antagonist therapy of cholestatic pruritus induced by an oral contraceptive.
Topics: Administration, Oral; Adolescent; Cholestasis, Intrahepatic; Contraceptives, Oral, Combined; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Naltrexone; Narcotic Antagonists; Pruritus; Treatment Outcome | 2005 |
Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cholestasis, Intrahepatic; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Naltrexone; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2005 |
Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.
Topics: Antipruritics; Cholestasis, Intrahepatic; Humans; Naltrexone; Pilot Projects; Pruritus; Quality of Life; Treatment Outcome | 1996 |